- Breast
- Lung
- Gastrointestinal
- Genitourinary
- Leukemia
- Lymphoma
- Myeloma
- Hematologic Malignancies
- Head and Neck
- General Oncology
- Palliative Care
- Events
Playback speed
10 seconds
2021 Advanced NSCLC Targeted Therapy Updates: Efficacy & Safety Profile of Larotrectinib & Entrectinib for NTRK Fusion, Dabrafenib+Trametinib Combo in BRAF Mutated Disease
By
Virtual West Oncology Conference
FEATURING
Erminia Massarelli
By
Virtual West Oncology Conference
FEATURING
Erminia Massarelli
151 views
March 4, 2021
Comments 0
Login to view comments.
Click here to Login